Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells

Particle and Fibre Toxicology

Volumn 10, Issue 1, 2013, Pages

  Wu, Hsin Ying ^a   Chung, Min Chun ^a   Wang, Chia Chi ^b   Huang, Chung Hsiung ^a   Liang, Hong Jen ^c   Jan, Tong Rong ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Cathepsin B; Interleukin 1 ; Iron oxide nanoparticle; Lipopolysaccharide; Microglia; Secretory lysosome

Indexed keywords

CATHEPSIN B; ECTODYSPLASIN A; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ALKALINITY; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LYSOSOME; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL;

MURINAE;

ANIMALS; CATHEPSIN B; CELL SURVIVAL; CELLS, CULTURED; DEXTRANS; FLOW CYTOMETRY; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LYSOSOMES; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; MICROGLIA; MICROSCOPY, CONFOCAL; NANOPARTICLES; PRIMARY CELL CULTURE; SECRETORY PATHWAY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884179447     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-10-46     Document Type: Article

References (53)

1. Xie J, Huang J, Li X, Sun S, Chen X. Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 2009, 16:1278-1294. 10.2174/092986709787846604, 19355885.
2. Yu MK, Jeong YY, Park J, Park S, Kim JW, Min JJ, Kim K, Jon S. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed Engl 2008, 47:5362-5365. 10.1002/anie.200800857, 18551493.
3. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896. 10.1021/nn800072t, 2751731, 19206485.
4. Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul 1996, 13:245-255. 10.3109/02652049609026013, 8860681.
5. Shen CC, Wang CC, Liao MH, Jan TR. A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice. Int J Nanomedicine 2011, 6:1229-1235. 3131189, 21753874.
6. Lunov O, Syrovets T, Buchele B, Jiang X, Rocker C, Tron K, Nienhaus GU, Walther P, Mailander V, Landfester K, Simmet T. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010, 31:5063-5071. 10.1016/j.biomaterials.2010.03.023, 20381862.
7. Chen BA, Jin N, Wang J, Ding J, Gao C, Cheng J, Xia G, Gao F, Zhou Y, Chen Y, et al. The effect of magnetic nanoparticles of Fe(3)O(4) on immune function in normal ICR mice. Int J Nanomedicine 2010, 5:593-599. 2939704, 20856834.
8. Cho WS, Cho M, Kim SR, Choi M, Lee JY, Han BS, Park SN, Yu MK, Jon S, Jeong J. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. Toxicol Appl Pharmacol 2009, 239:106-115. 10.1016/j.taap.2009.05.026, 19520096.
9. Hsiao JK, Chu HH, Wang YH, Lai CW, Chou PT, Hsieh ST, Wang JL, Liu HM. Macrophage physiological function after superparamagnetic iron oxide labeling. NMR Biomed 2008, 21:820-829. 10.1002/nbm.1260, 18470957.
10. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010, 30:15-35. 10.1038/jcbfm.2009.192, 2949106, 19756021.
11. Thorek DL, Weisshaar CL, Czupryna JC, Winkelstein BA, Tsourkas A. Superparamagnetic iron oxide-enhanced magnetic resonance imaging of neuroinflammation in a rat model of radicular pain. Mol Imaging 2011, 10:206-214.
12. Jin AY, Tuor UI, Rushforth D, Filfil R, Kaur J, Ni F, Tomanek B, Barber PA. Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle. Contrast Media Mol Imaging 2009, 4:305-311. 10.1002/cmmi.292, 19941323.
13. Aloisi F. Immune function of microglia. Glia 2001, 36:165-179. 10.1002/glia.1106, 11596125.
14. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318. 10.1016/0166-2236(96)10049-7, 8843599.
15. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985, 228:497-499. 10.1126/science.3872478, 3872478.
16. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 1995, 20:269-287. 10.1016/0165-0173(94)00015-H, 7550361.
17. Lee SC, Dickson DW, Brosnan CF. Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav Immun 1995, 9:345-354. 10.1006/brbi.1995.1032, 8903851.
18. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin-1beta promotes repair of the CNS. J Neurosci 2001, 21:7046-7052.
19. Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012, 87:10-20. 10.1016/j.brainresbull.2011.10.004, 22024597.
20. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002, 40:140-155. 10.1002/glia.10161, 12379902.
21. Hutter E, Boridy S, Labrecque S, Lalancette-Hebert M, Kriz J, Winnik FM, Maysinger D. Microglial response to gold nanoparticles. ACS Nano 2010, 4:2595-2606. 10.1021/nn901869f, 20329742.
22. Wang Y, Wang B, Zhu MT, Li M, Wang HJ, Wang M, Ouyang H, Chai ZF, Feng WY, Zhao YL. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 2011, 205:26-37. 10.1016/j.toxlet.2011.05.001, 21596115.
23. Shen CC, Liang HJ, Wang CC, Liao MH TRJ. A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression. Int J Nanomedicine 2011, 6:2791-2798. 3218589, 22114506.
24. Mou Y, Chen B, Zhang Y, Hou Y, Xie H, Xia G, Tang M, Huang X, Ni Y, Hu Q. Influence of synthetic superparamagnetic iron oxide on dendritic cells. Int J Nanomedicine 2011, 6:1779-1786. 3184937, 21980240.
25. Yang CY, Tai MF, Lin CP, Lu CW, Wang JL, Hsiao JK, Liu HM. Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PloS one 2011, 6:e25524. 10.1371/journal.pone.0025524, 3182225, 21991395.
26. Yeh CH, Hsiao JK, Wang JL, Sheu F. Immunological impact of magnetic nanoparticles (Ferucarbotran) on murine peritoneal macrophages. J Nanoparticle Res : Interdiscip Forum Nanoscale Sci Technol 2010, 12:151-160.
27. Ankamwar B, Lai TC, Huang JH, Liu RS, Hsiao M, Chen CH, Hwu YK. Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnol 2010, 21:75102.
28. Li X, Xu S, Zhang Z, Schluesener H. Apoptosis induced by titanium dioxide nanoparticles in cultured murine microglia N9 cells. Chin Sci Bull 2009, 54:3830-3836.
29. Yeh C-H, Hsiao J-K, Wang J-L, Sheu F. Immunological impact of magnetic nanoparticles (Ferucarbotran) on murine peritoneal macrophages. J Nanopart Res 2010, 12:151-160.
30. Chauvet N, Palin K, Verrier D, Poole S, Dantzer R, Lestage J. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur J Neurosci 2001, 14:609-617. 10.1046/j.0953-816x.2001.01686.x, 11556886.
31. Black RA. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 2002, 34:1-5. 10.1016/S1357-2725(01)00097-8, 11733179.
32. Stow JL, Low PC, Offenhauser C, Sangermani D. Cytokine secretion in macrophages and other cells: pathways and mediators. Immunobiol 2009, 214:601-612.
33. Lacy P, Stow JL. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 2011, 118:9-18. 10.1182/blood-2010-08-265892, 21562044.
34. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003, 270:2109-2119. 10.1046/j.1432-1033.2003.03577.x, 12752430.
35. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009, 10:148-155. 10.1038/nrm2617, 19122676.
36. Eder C. Mechanisms of interleukin-1beta release. Immunobiol 2009, 214:543-553.
37. Choi J, Zheng Q, Katz HE, Guilarte TR. Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect 2010, 118:589-595. 2866671, 20439179.
38. Lunov O, Syrovets T, Rocker C, Tron K, Nienhaus GU, Rasche V, Mailander V, Landfester K, Simmet T. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 2010, 31:9015-9022. 10.1016/j.biomaterials.2010.08.003, 20739059.
39. Terada K, Yamada J, Hayashi Y, Wu Z, Uchiyama Y, Peters C, Nakanishi H. Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia 2010, 58:114-124. 10.1002/glia.20906, 19544382.
40. Lunov O, Zablotskii V, Syrovets T, Rocker C, Tron K, Nienhaus GU, Simmet T. Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials 2011, 32:547-555. 10.1016/j.biomaterials.2010.08.111, 20880574.
41. Luther EM, Petters C, Bulcke F, Kaltz A, Thiel K, Bickmeyer U, Dringen R. Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells. Acta biomaterialia 2013, 9:8454-8465. 10.1016/j.actbio.2013.05.022, 23727247.
42. Blott EJ, Griffiths GM. Secretory lysosomes. Nat Rev Mol Cell Biol 2002, 3:122-131. 10.1038/nrm732, 11836514.
43. Griffiths G. What's special about secretory lysosomes?. Semin Cell Dev Biol 2002, 13:279-284. 10.1016/S1084-9521(02)00057-5, 12243727.
44. Elstak ED, Neeft M, Nehme NT, Voortman J, Cheung M, Goodarzifard M, Gerritsen HC, van Bergen En Henegouwen PM, Callebaut I, de Saint Basile G, van der Sluijs P. The munc13-4-rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane. Blood 2011, 118:1570-1578. 10.1182/blood-2011-02-339523, 21693760.
45. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010, 12:19-30. sup pp 11-13, 10.1038/ncb2000, 19966785.
46. Guha S, Padh H. Cathepsins: fundamental effectors of endolysosomal proteolysis. Indian J Biochem Biophys 2008, 45:75-90.
47. Mort JS, Buttle DJ. Cathepsin B. Int J Biochem Cell Biol 1997, 29:715-720. 10.1016/S1357-2725(96)00152-5, 9251238.
48. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003, 299:1400-1403. 10.1126/science.1080106, 12610307.
49. Ma X, Wu Y, Jin S, Tian Y, Zhang X, Zhao Y, Yu L, Liang XJ. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 2011, 5:8629-8639. 10.1021/nn202155y, 21974862.
50. Smith ME, van der Maesen K, Somera FP. Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production. J Neurosci Res 1998, 54:68-78. 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F, 9778151.
51. Honey K, Rudensky AY. Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 2003, 3:472-482. 10.1038/nri1110, 12776207.
52. Long TC, Tajuba J, Sama P, Saleh N, Swartz C, Parker J, Hester S, Lowry GV, Veronesi B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 2007, 115:1631-1637. 10.1289/ehp.10216, 2072833, 18007996.
53. Correa F, Docagne F, Mestre L, Clemente D, Hernangomez M, Loria F, Guaza C. A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol 2009, 77:86-100. 10.1016/j.bcp.2008.09.014, 18848818.